Expense Ratio Rating
1 /10
Expense Rating
0 /10
Market Score
8 /10
Category Score
0 /10
Market Size
8 /10
$PHLCX Alternatives
Different Funds
We found 10,815 Sector Equity Healthcare funds. Here they are ordered by FI Score.
- naefx
- Mutual Fund
- Allocation
- Total World
New Alternatives Fund Investor Shares
Expenses: 1.33% (Better than 0% of similar funds)
This is a bad choice for a Total World Allocation fund. See why »
- psmcx
- Mutual Fund
- US Stocks
- Small Blend
Principal SmallCap Fund Class C
Expenses: 2.04% (Better than 0% of similar funds)
This is a bad choice for a Small Blend US Stocks fund. See why »
- nchcx
- Mutual Fund
- Bond
- Municipal Bond
Nuveen California High Yield Municipal Bond Fund Class C2
Expenses: 1.76% (Better than 0% of similar funds)
This is a bad choice for a Municipal Bond Bond fund. See why »
- pubcx
- Mutual Fund
- Bond
- High Yield Bond
PIMCO Dynamic Bond Fund Class C
Expenses: 2.00% (Better than 0% of similar funds)
This is a bad choice for a High Yield Bond Bond fund. See why »
- bisax
- Mutual Fund
- International Stocks
- Mid-Cap Value
Brandes International Small Cap Equity Fund Class A
Expenses: 1.35% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Value International Stocks fund. See why »
- biopx
- Mutual Fund
- US Stocks
- Large Growth
Baron Opportunity Fund Retail Class
Expenses: 1.34% (Better than 0% of similar funds)
This is a bad choice for a Large Growth US Stocks fund. See why »
- bmccx
- Mutual Fund
- US Stocks
- Large Growth
BlackRock Advantage Large Cap Growth Fund Investor C Shares
Expenses: 1.62% (Better than 0% of similar funds)
This is a bad choice for a Large Growth US Stocks fund. See why »
- bopcx
- Mutual Fund
- US Stocks
- Large Blend
Sterling Capital Special Opportunities Fund Class C
Expenses: 1.86% (Better than 0% of similar funds)
This is a bad choice for a Large Blend US Stocks fund. See why »
- boss
- ETF
- US Stocks
- Mid-Cap Growth
Global X Founder-Run Companies ETF
Expenses: 0.45% (Better than 1% of similar funds)
This is a bad choice for a Mid-Cap Growth US Stocks fund. See why »